Last reviewed · How we verify
Attention deficit hyperactivity disorder
Approved treatments
- Xelstrym · UCB
Xelstrym works by blocking the reuptake of noradrenaline, allowing it to stay in the brain for longer and increasing alertness and focus. - Azstarys · Commcave Therapeutics Sa
Azstarys increases levels of dopamine and norepinephrine in the brain to help regulate attention and impulse control. - Catapres-Tts-1 · Lavipharm
- Vyvanse · Takeda
Vyvanse works by blocking the dopamine transporter, allowing more dopamine to be available in the brain. - Amphetamine Sulfate · UCB
- Desoxyn · Ajenat Pharms
Amphetamines are non-catecholamine sympathomimetic amines with CNS stimulant activity. - Amphetamine Sulfate · Azurity
- Focalin · Novartis
Focalin works by blocking the dopamine transporter, allowing more dopamine to be available in the brain. - Pemolin
- Ritalin · Novartis
- Clonidin · Medical University of Vienna
- Concerta · Lei Lei, MD
- Adaptol
Adaptol is thought to work by modulating neurotransmitter activity in the brain. - Strattera · University of Oklahoma
- Tenex · Promius Pharma
Tenex works by stimulating alpha-2 adrenergic receptors in the brain, which helps to reduce the activity of certain nerve cells. - Strattera · Eli Lilly
Strattera works by blocking the reabsorption of norepinephrine in the brain, allowing more of this neurotransmitter to be available for use. - SERD · Fudan University
- Vyvanse · Vanderbilt University
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Attention deficit hyperactivity disorder patent landscape — cliff calendar, originator estates, attackable patents
- Attention deficit hyperactivity disorder treatment landscape brief
- Attention deficit hyperactivity disorder treatment updates RSS
Frequently asked questions about Attention deficit hyperactivity disorder
What drugs treat Attention deficit hyperactivity disorder?
Tracked treatments include Xelstrym, Azstarys, Catapres-Tts-1, Vyvanse, Amphetamine Sulfate, Desoxyn, Focalin, Pemolin.
What is the treatment for Attention deficit hyperactivity disorder?
Standard treatment for Attention deficit hyperactivity disorder includes Xelstrym, Azstarys, Catapres-Tts-1, Vyvanse, Amphetamine Sulfate. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Attention deficit hyperactivity disorder patent cliff · Attention deficit hyperactivity disorder CI report
- Treatment: Xelstrym · UCB
- Treatment: Azstarys · Commcave Therapeutics Sa
- Treatment: Catapres-Tts-1 · Lavipharm
- Treatment: Vyvanse · Takeda
- Treatment: Amphetamine Sulfate · UCB
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing